These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8428088)

  • 1. Use of MR imaging contrast agents in the brain.
    Bradley WG; Yuh WT; Bydder GM
    J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine use of gadopentetate dimeglumine in cranial MR imaging of patients with AIDS.
    Elster AD
    AJR Am J Roentgenol; 1993 Sep; 161(3):680-1. PubMed ID: 8352135
    [No Abstract]   [Full Text] [Related]  

  • 3. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
    Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R
    Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
    Higer HP; Just M; Grigat M; Meindl S; Jungke M; Bielke G; Pedrosa P; Kunze S; Voth D
    Rofo; 1988 Mar; 148(3):307-13. PubMed ID: 2832897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 7. Gadolinium-enhanced MRI of intracranial lesions. A review of indications and results.
    Wilms G; Marchal G; Demaerel PH; Van Hecke P; Baert AL
    Clin Imaging; 1991; 15(3):153-65. PubMed ID: 1933642
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
    Dewulf P; Demaerel P; Wilms G; Delanote G; Defloor E; Casselman J; Baert AL
    J Belge Radiol; 1993 Oct; 76(5):318-9. PubMed ID: 8119873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging in chronic partial epilepsy: role of contrast enhancement.
    Elster AD; Mirza W
    AJNR Am J Neuroradiol; 1991; 12(1):165-70. PubMed ID: 1903576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual MR and CT appearance of an epidermoid tumor.
    Gualdi GF; Di Biasi C; Trasimeni G; Pingi A; Vignati A; Maira G
    AJNR Am J Neuroradiol; 1991; 12(4):771-2. PubMed ID: 1882763
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
    Mirowitz SA
    Radiology; 1992 Nov; 185(2):529-34. PubMed ID: 1410367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional MR imaging and display of intracranial disease: improvements with the MP-RAGE sequence and gadolinium.
    Brant-Zawadzki MN; Gillan GD; Atkinson DJ; Edalatpour N; Jensen M
    J Magn Reson Imaging; 1993; 3(4):656-62. PubMed ID: 8347960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-DTPA in magnetic resonance imaging of the brain.
    Valk J; De Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI
    Neurosurg Rev; 1987; 10(2):87-92. PubMed ID: 3448513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging contrast agents.
    Runge VM
    Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of contrast media for magnetic resonance imaging.
    Goldstein HA; Wiggins JR; Kashanian F
    Ann N Y Acad Sci; 1992 Mar; 649():322-31. PubMed ID: 1580503
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images.
    Wheeler AL; Truwit CL; Kleinschmidt-DeMasters BK; Byrne WR; Hannon RN
    AJR Am J Roentgenol; 1993 Nov; 161(5):1049-51. PubMed ID: 8273607
    [No Abstract]   [Full Text] [Related]  

  • 18. Inflammatory joint disease: static and dynamic gadolinium-enhanced MR imaging.
    Reiser MF; Naegele M
    J Magn Reson Imaging; 1993; 3(1):307-10. PubMed ID: 8428098
    [No Abstract]   [Full Text] [Related]  

  • 19. Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities?
    Kransdorf MJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1545. PubMed ID: 7484606
    [No Abstract]   [Full Text] [Related]  

  • 20. Miliary tuberculosis involving the brain: MR findings.
    Gee GT; Bazan C; Jinkins JR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1075-6. PubMed ID: 1414778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.